18.81
+0.15
(0.80%)
May 17 - Close
NASDAQ
real-time data -
Disclaimer
Currency in USD
| Range | 18.59 - 18.82 |
| 52 week | 12.33 - 20.00 |
| Open | 18.71 |
| Vol / Avg. | 118,422.00/149,734.00 |
| Mkt cap | 645.78M |
| P/E | 37.65 |
| Div/yield | - |
| EPS | 0.50 |
| Shares | 34.33M |
| Beta | 1.05 |
| Inst. own | 91% |
Events
Aug 2, 2013
Q2 2013 Omnicell, Inc. Earnings Release
May 21, 2013
Omnicell, Inc. at B. Riley & Co. Investor Conference
- 6:30PM EDT -
May 3, 2013
Q1 2013 Omnicell, Inc. Earnings Release
May 2, 2013
Q1 2013 Omnicell, Inc. Earnings Conference Call
Mar 5, 2013
Omnicell, Inc. at Cowen Health Care Conference
|
More events from DailyFinance »
|
Key stats and ratios
| Q1 (Mar '13) | 2012 | |
| Net profit margin | 3.89% | 5.15% |
| Operating margin | 4.79% | 8.64% |
| EBITD margin | - | 12.88% |
| Return on average assets | 3.02% | 4.02% |
| Return on average equity | 4.31% | 5.48% |
| Employees | 1,089 | - |
| Carbon Disclosure Rating | - | - |
Address
590 E. Middlefield Road
MOUNTAIN VIEW, CA 94043-1337
United States - Map
+1-650-2516100 (Phone)
+1-650-2516266 (Fax)
MOUNTAIN VIEW, CA 94043-1337
United States - Map
+1-650-2516100 (Phone)
+1-650-2516266 (Fax)
Website links
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Research Reports - Reuters
Discussion Group - Google Finance
Volume delayed by 15 mins.
Advertisement
Description
Omnicell, Inc. (Omnicell) is a provider of automated solutions for hospital medication and supply management. The Company�s automation and analytics solutions are designed to enable healthcare facilities to acquire, manage, dispense and administer medications and medical-surgical supplies. Its systems provide medication control and dispensing solution starting from the point of entry into the hospital and other health care providers, through the central pharmacy, to the nursing station and to the patient's bedside. Omincell�s medication-use product line includes its OmniRx, SinglePointe, AnywhereRN, Anesthesia Workstation, WorkflowRx, Controlled Substance Management, OmniLinkRx, Savvy Mobile Medication System, and Pandora Data Analytics products. In May 2012, the Company acquired MTS Medication Technologies, Inc.
Officers and directors
| Randall A. Lipps | Chairman of the Board, President, Chief Executive Officer | |
| Robin G. Seim | Chief Financial Officer, Executive Vice President - Finance, Administration and Manufacturing | |
| Dan S. Johnston | Executive Vice President, General Counsel | |
| Marga Ortigas-Wedekind | Executive Vice President - Global Marketing and Product Development | |
| J. Christopher Drew | Executive Vice President - Field Operations | |
| Nhat H. Ngo | Executive Vice President - Strategy and Business Development | |
| Michael D. Stevenson | Executive Vice President - Global Manufacturing | |
| Jorge R. Taborga | Executive Vice President - Engineering | |
| Donald C. Wegmiller | Lead Independent Director | |
| Mark W. Parrish | Director |
